Look for:

BASILEA PHARMACEU


ISIN:
CH0011432447
WKN:
1143244

2024/01/25 17:32:23
Price
34.0277 CHF
Difference -2.36% (-0.82)

General attributes

ISINCH0011432447
SymbolBSLN
ExchangeLondon Stock Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)516 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)45.05 CHF (1,000)
Ask (Ask size)47.35 CHF (1,000)
Open34.0277 CHF
High34.0277 CHF
Low34.0277 CHF
Close (prev. day)34.8486 CHF
VWAP34.02772 CHF
Volume (pcs)6,855
Trading volume233,260.02
Number of trades1
Last size6,855

Futures and Options

Related Futures15
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/01/25 17:32:23
Price
34.0277 CHF
Difference -2.36% (-0.82)

General attributes

ISINCH0011432447
SymbolBSLN
ExchangeLondon Stock Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)516 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)45.05 CHF (1,000)
Ask (Ask size)47.35 CHF (1,000)
Open34.0277 CHF
High34.0277 CHF
Low34.0277 CHF
Close (prev. day)34.8486 CHF
VWAP34.02772 CHF
Volume (pcs)6,855
Trading volume233,260.02
Number of trades1
Last size6,855

Performance and Risk

6m1y3y
Perf (%)---
Perf (abs.)---
Beta0.570.540.87
Volatility18.8616.6460.60
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)- CHF (289)
Ø price 30 days | Ø volume 30 days (pcs.)- CHF (-)
Ø price 100 days | Ø volume 100 days (pcs.)34.7760 CHF (1,733)
Ø price 250 days | Ø volume 250 days (pcs.)37.1408 CHF (707)
YTD High | date34.9500 CHF (2024/01/24)
YTD Low | date34.0277 CHF (2024/01/25)
52 Weeks High | date46.6000 CHF (2023/09/14)
52 Weeks Low | date34.0277 CHF (2024/01/25)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Stuttgart2019/06/2817:1932.60 EUR0.028
SIX Swiss Exchange2024/04/1813:1841.45 CHF0.66185
London Stock Exchange2024/01/2517:3234.0277 CHF0.231
Frankfurt2019/06/2815:4332.28 EUR0.003
FINRA other OTC Issues2024/04/1019:5644.45 USD0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=3790&ID_TYPE_IMAGE_LOGO=2

Contact Details

BASILEA PHARMACEUTICA AG
- -
Hegenheimermattweg 167b - 4123 Allschwil
Telefon: +41-61-606-11-11
Fax: +
E-mail: info@basilea.com

Company Profile

-

Members of Management Board

David VeitchChairman of Managing Board
Gerrit HauckMember of Executive Committee
Laurenz KellenbergerMember of Executive Committee
Marc EngelhardtMember of Executive Committee
Adesh KaulMember of Executive Committee

Board of directors

Alf Gunnar Martin NicklassonMember of the administrative board
Carole SableMember of the administrative board
Nicole OnettoMember of the administrative board
Thomas WernerMember of the administrative board
Leonard KruimerMember of the administrative board
Domenico ScalaChairman of the administrative boar





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.